A more comprehensive understanding of how DDX4 and other DEAD/H‐box helicases modulate IFN responses could open new therapeutic avenues for treating various human diseases, with potential applications beyond limiting viral infection. This evidence concerns the gene DDX4 and viral infectious disease.